Stockscreener 앱 받기
2.04
4.62%
0.09
전일 마감가:
$1.95
열려 있는:
$1.97
하루 거래량:
73,360
Relative Volume:
0.61
시가총액:
$24.59M
수익:
$52.16M
순이익/손실:
$-48.60M
주가수익비율:
-0.4722
EPS:
-4.32
순현금흐름:
$-77.48M
1주 성능:
+9.68%
1개월 성능:
+0.99%
6개월 성능:
-68.22%
1년 성능:
-69.10%
1일 변동 폭
$1.9304
$2.07
1주일 범위
$1.80
$2.07
52주 변동 폭
$1.715
$10.50
Hookipa Pharma Inc Stock (HOOK) Company Profile
명칭
Hookipa Pharma Inc
전화
0114318906360
주소
350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240, NEW YORK, NY
HOOK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOOK
Hookipa Pharma Inc
|
2.04 | 24.59M | 52.16M | -48.60M | -77.48M | -4.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Hookipa Pharma Inc Stock (HOOK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-20 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-11-15 | 재확인 | RBC Capital Mkts | Outperform |
| 2022-12-02 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2021-11-12 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-08 | 개시 | Morgan Stanley | Overweight |
| 2020-11-03 | 개시 | Truist | Buy |
| 2020-10-26 | 개시 | JMP Securities | Mkt Outperform |
| 2020-10-19 | 재개 | H.C. Wainwright | Buy |
| 2019-09-27 | 개시 | H.C. Wainwright | Buy |
| 2019-05-13 | 개시 | BofA/Merrill | Buy |
| 2019-05-13 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Hookipa Pharma Inc 주식(HOOK)의 최신 뉴스
HOOK (HOOKIPA Pharma) Shares Outstanding (EOP) : 12.05 Mil (As of Sep. 2024) - GuruFocus.com
Hookipa Pharma stock hits 52-week low at $1.73 amid market challenges - Investing.com Nigeria
Geode Capital Management LLC Cuts Stake in Hookipa Pharma Inc (NASDAQ:HOOK) - Defense World
HC Wainwright Reiterates Neutral Rating for Hookipa Pharma (NASDAQ:HOOK) - Defense World
HOOKIPA Pharma explores acquisition of Poolbeg Pharma By Investing.com - Investing.com South Africa
HOOKIPA Pharma explores acquisition of Poolbeg Pharma - Investing.com
Poolbeg Pharma notes Gilead interest in Hookipa fundraise -January 10, 2025 at 11:08 am EST - Marketscreener.com
Poolbeg Pharma update on potential combination with HOOKIPA - DirectorsTalk Interviews
Poolbeg Pharma PLC (AIM:POLB) Update Potential Combination of Poolbeg & HOOKIPA - Share Talk
Poolbeg Pharma plc ('Poolbeg”) and HOOKIPA Pharma Inc. ('HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA - The Manila Times
Poolbeg Pharma and HOOKIPA Explore Potential Merger Amid Gilead’s Interest - TipRanks
Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. - GlobeNewswire
Gilead Sciences Backs HOOKIPA-Poolbeg Merger Talks with $8.7M Funding Commitment - StockTitan
HOOKIPA Pharma discloses position in takeover code filing By Investing.com - Investing.com Nigeria
HOOKIPA Pharma Inc. Enters Non-Binding Discussions for Potential Acquisition of Poolbeg Pharma plc - Defense World
HOOKIPA Pharma discloses position in takeover code filing - Investing.com India
UPDATEMyriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
HOOKIPA Pharma IncFORM 8 (OPD) - GlobeNewswire
HOOKIPA Pharma Discloses Executive Stock Holdings, Awards Major RSU Grants to Leadership - StockTitan
HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements - The Manila Times
HOOKIPA Pharma Issues Key Disclosure Notice for Poolbeg Pharma Acquisition Plans - StockTitan
Poolbeg and HOOKIPA progress toward potential merger By Investing.com - Investing.com Australia
HOOKIPA Pharma in talks to acquire Poolbeg Pharma By Investing.com - Investing.com Australia
HOOKIPA Pharma in talks to acquire Poolbeg Pharma - Investing.com
HOOKHOOKIPA Pharma Inc. Latest Stock News & Market Updates - StockTitan
Poolbeg and HOOKIPA progress toward potential merger - Investing.com India
Gilead backs proposed Poolbeg Pharma's proposed tie-up with HOOKIPA - Proactive Investors UK
Poolbeg and HOOKIPA Explore Potential Merger with Gilead’s Support - TipRanks
Gilead Sciences Backs Poolbeg-HOOKIPA Merger as Fundraising Target Expands to $30M+ - StockTitan
HOOKIPA Pharma Inc. (“HOOKIPA”) Rule 2.9 Announcement – Amendment - GlobeNewswire
HOOKIPA Pharma Updates Merger Talks with Poolbeg, Clarifies Post-Split Share Structure - StockTitan
State Street Corp Cuts Stake in Hookipa Pharma Inc (NASDAQ:HOOK) - Defense World
HOOKIPA Pharma Inc. in Non-Binding Discussions for Potential Acquisition of Poolbeg Pharma plc - Defense World
London-listed Poolbeg discussing Hookipa merger - pharmaphorum
Poolbeg Startles Investors With Plan To Hook Up With Hookipa - News & Insights
HOOKIPA Pharma in early talks to acquire Poolbeg - The Pharma Letter
HOOKIPA (HOOK) Shares Climb Premarket On Merger News - Stocks Telegraph
RNS Hotlist with Zak Mir: POLB, HOOK, COIN, QED, CGO, CEL, CIZ & EML - Share Talk
HOOKIPA Pharma and Poolbeg discuss all-share acquisition - DirectorsTalk Interviews
Poolbeg Pharma PLC (AIM:POLB) Combination of Poolbeg and HOOKIPA Pharma Inc. - Share Talk
Poolbeg in early talks to combine with US biotech - Proactive financial news
Hookipa Pharma Inc (HOOK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.81%
자본화:
|
볼륨(24시간):